LeMaitre Vascular, Inc.
LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion cathetersā¦ read more
Healthcare
Medical Instruments & Supplies
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$90.95
Price+0.38%
$0.34
1Y
Price
Market Cap
$2.063b
Mid
Price/Earnings 3y Avg5y Avg
39.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+43.4%
EBITDA Margin+28.4%
Net Profit Margin+43.4%
Free Cash Flow Margin+43.4%
EBITDA Margin+28.4%
Net Profit Margin+43.4%
Free Cash Flow MarginRevenue
$240.866m
+9.6%
1y CAGR+14.3%
3y CAGR+11.9%
5y CAGREarnings
$53.336m
+21.1%
1y CAGR+37.8%
3y CAGR+22.5%
5y CAGREPS
$2.32
+20.2%
1y CAGR+36.1%
3y CAGR+20.7%
5y CAGRBook Value
$378.923m
$598.069m
Assets$219.146m
Liabilities$185.632m
DebtDebt to Assets
31.0%
2.1x
Debt to EBITDAFree Cash Flow
$66.226m
+78.2%
1y CAGR+45.8%
3y CAGR+27.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company